ScholarIQanswers from OpenAlex & ORCID
Michael S. Oh
ResearcherPublications, citations & collaboration network
Michael S. Oh is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Michael S. Oh have?
ScholarIQindexed works
Michael S. Oh has 88 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Michael S. Oh have?
ScholarIQcitation count
Michael S. Oh has 1,392 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Michael S. Oh?
ScholarIQh-index
Michael S. Oh has an h-index of 20 in OpenAlex.
What is the i10-index of Michael S. Oh?
ScholarIQi10-index
Michael S. Oh has an i10-index of 27 in OpenAlex.
What is the ORCID of Michael S. Oh?
ScholarIQorcid
The ORCID for Michael S. Oh is on the source record.
What is the OpenAlex record for Michael S. Oh?
ScholarIQopenalex
The OpenAlex for Michael S. Oh is on the source record.
What are the most-cited papers on Michael S. Oh?
ScholarIQmost cited works
The leukodystrophy protein FAM126A (hyccin) regulates PtdIns(4)P synthesis at the plasma membrane
Jeremy M. Baskin, Xudong Wu, Romain Christiano, Michael S. Oh, Curtis Schauder, Elisabetta Gazzerro, Mirko Messa, Sımona Baldassari, Stefania Assereto, Roberta Biancheri, Federico Zara, Carlo Minetti, Andrea Raimondi, Mikael Simons, Tobias C. Walther, Karin M. Reinisch, Pietro De Camilli
Detection of Minimal Residual Disease Using ctDNA in Lung Cancer: Current Evidence and Future Directions
Young Kwang Chae, Michael S. Oh
Cholesterol-tethered platinum II-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicity
Poulomi Sengupta, Sudipta Basu, Shivani Soni, Ambarish Pandey, Bhaskar Roy, Michael S. Oh, Kenneth T. Chin, Abhimanyu S. Paraskar, Sasmit Sarangi, Yamicia Connor, Venkata Sabbisetti, Jawahar Kopparam, Ashish Kulkarni, Katherine W. Muto, Chitra Amarasiriwardena, Innocent Jayawardene, Nicola Lupoli, Daniela M. Dinulescu, Joseph V. Bonventre, R. A. Mashelkar, Shiladitya Sengupta
CXCL9/10-engineered dendritic cells promote T cell activation and enhance immune checkpoint blockade for lung cancer
Raymond J. Lim, Ramin Salehi‐Rad, Linh M. Tran, Michael S. Oh, Camelia Dumitras, William P. Crosson, Rui Li, Tejas S. Patel, Samantha Man, Cara E. Yean, Jensen Abascal, ZiLing Huang, Stephanie L. Ong, Kostyantyn Krysan, Steven M. Dubinett, Bin Liu
Analysis of Cell-Free DNA from 32,989 Advanced Cancers Reveals Novel Co-occurring Activating <i>RET</i> Alterations and Oncogenic Signaling Pathway Aberrations
Thereasa A. Rich, Karen L. Reckamp, Young Kwang Chae, Robert C. Doebele, Wade T. Iams, Michael S. Oh, Victoria M. Raymond, Richard B. Lanman, Jonathan W. Riess, Thomas E. Stinchcombe, Vivek Subbiah, David R. Trevarthen, Stephen R. Fairclough, Jennifer Yen, Oliver Gautschi